On Mar 2, 2022 Epsilogen closed a Series B round and raised £30,750,000 from 3B Future Health Fund, ALSA Ventures, British Patient Capital, Caribou Property, […]
Series A – Rondo Therapeutics
On Mar 2, 2022 Rondo Therapeutics closed a Series A round and raised $67,000,000 from Canaan Partners, Johnson & Johnson Innovation – JJDC, Novo Holdings, […]
Nines acquired by Sirona Medical
Feb 18, 2022 Sirona Medical has entered into an agreement to acquire Nines . Sirona Medical based at San Francisco, California, United States. “Based in […]
Series C – Variantyx
On Feb 14, 2022 Variantyx closed a Series C round and raised $41,500,000 from 20/20 HealthCare Partners, New Era Capital Partners, Peregrine Ventures, Pitango Venture […]
Pre Seed Round – Adaptyv Biosystems
On Feb 14, 2022 Adaptyv Biosystems closed a Pre-Seed round and raised CHF2,500,000 from Acequia Capital, Axial VC, FAST — by GETTYLAB, Founders, Hawktail Management, Rheingau […]
Series C – Variantyx
On Feb 14, 2022 Variantyx closed a Series C round and raised $41,500,000 from 20/20 HealthCare Partners, New Era Capital Partners, Peregrine Ventures, Pitango Venture […]
Post-IPO Equity – Enveric Biosciences
On Feb 11, 2022 Enveric Biosciences closed a Post-IPO Equity round and raised $10,000,000 from investors, featuring lead investors . About the company: Enveric Biosciences […]
Seed Round – Celeris Therapeutics
On Feb 10, 2022 Celeris Therapeutics closed a Seed round and raised €3,000,000 from i&i Prague, Longevitytech.fund, Pace Ventures Enigma, R42 Group, featuring lead investors […]
Series B – Simcha Therapeutics
On Jan 27, 2022 Simcha Therapeutics closed a Series B round and raised $40,000,000 from ArrowMark Partners, BVF Partners, Logos Capital, Rock Springs Capital, Samsara […]
Series C – Enable Injections
On Jan 27, 2022 Enable Injections closed a Series C round and raised $215,000,000 from Cincinnati Children’s, CincyTech, Cintrifuse, GCM Grosvenor, Magnetar Capital, Ohio Innovation […]
